Association between smoking habits and the first-time appearance of atrial fibrillation in Japanese patients: Evidence from the Shinken Database

Journal of Cardiology

Volumn 66, Issue 1, 2015, Pages 73-79

  Suzuki, Shinya ^a   Otsuka, Takayuki ^a   Sagara, Koichi ^a   Kano, Hiroto ^a   Matsuno, Shunsuke ^a   Takai, Hideaki ^a   Kato, Yuko ^a   Uejima, Tokuhisa ^a   Oikawa, Yuji ^a   Nagashima, Kazuyuki ^a   Kirigaya, Hajime ^a   Kunihara, Takashi ^a   Yajima, Junji ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a   Yamashita, Takeshi ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

Atrial fibrillation; Epidemiology; Risk factors; Smoking; Tobacco consumption

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; ATRIAL FIBRILLATION; BRINKMAN INDEX; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JAPAN; JAPANESE (PEOPLE); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKING CESSATION; SMOKING HABIT; TOBACCO CONSUMPTION; URBAN AREA; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; FACTUAL DATABASE; MIDDLE AGED; SMOKING;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; SMOKING;

EID: 84930928399     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.09.010     Document Type: Article

References (68)

1. Wolf P.A., Mitchell J.B., Baker C.S., Kannel W.B., D'Agostino R.B. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998, 158:229-234.
2. Wang T.J., Larson M.G., Levy D., Vasan R.S., Leip E.P., Wolf P.A., D'Agostino R.B., Murabito J.M., Kannel W.B., Benjamin E.J. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003, 107:2920-2925.
3. Okumura K., Komatsu T., Yamashita T., Okuyama Y., Harada M., Konta Y., Hatayama T., Horiuchi D., Tsushima E. Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. A multicenter study of its status and infuential factors. Circ J 2011, 75:2087-2094.
4. Ogawa S., Koretsune Y., Yasaka M., Aizawa Y., Atarashi H., Inoue H., Kamakura S., Kumagai K., Mitamura H., Okumura K., Sugi K., Yamashita T. Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents. Circ J 2011, 75:1539-1547.
5. Atarashi H., Inoue H., Okumura K., Yamashita T., Kumagai N., Origasa H., J-RHYTHM Registry Investigators Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011, 75:1328-1333.
6. Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285:2370-2375.
7. Ohsawa M., Okayama A., Sakata K., Kato K., Itai K., Onoda T., Ueshima H. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol 2005, 15:194-196.
8. Inoue H., Fujiki A., Origasa H., Ogawa S., Okumura K., Kubota I., Aizawa Y., Yamashita T., Atarashi H., Horie M., Ohe T., Doi Y., Shimizu A., Chishaki A., Saikawa T., et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2009, 137:102-107.
9. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994, 271:840-844.
10. Wang T.J., Parise H., Levy D., D'Agostino R.B., Wolf P.A., Vasan R.S., Benjamin E.J. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004, 292:2471-2477.
11. Watanabe H., Tanabe N., Watanabe T., Darbar D., Roden D.M., Sasaki S., Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008, 117:1255-1260.
12. Iguchi Y., Kimura K., Kobayashi K., Aoki J., Terasawa Y., Sakai K., Uemura J., Shibazaki K. Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 2008, 102:1056-1059.
13. Watanabe H., Watanabe T., Sasaki S., Nagai K., Roden D.M., Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009, 158:629-636.
14. Alonso A., Lopez F.L., Matsushita K., Loehr L.R., Agarwal S.K., Chen L.Y., Soliman E.Z., Astor B.C., Coresh J. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011, 123:2946-2953.
15. Horio T., Iwashima Y., Kamide K., Tokudome T., Yoshihara F., Nakamura S., Kawano Y. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens 2010, 28:1738-1744.
16. Anderson K.M., Odell P.M., Wilson P.W., Kannel W.B. Cardiovascular disease risk profiles. Am Heart J 1991, 121:293-298.
17. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
18. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., Kannel W.B. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
19. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J 2006, 70:1249-1255. Nippon Data Research Group.
20. Epstein F.H. The epidemiology of coronary heart disease. A review. J Chronic Dis 1965, 18:735-774.
21. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004, 43:1731-1737.
22. Read R.C. Presidential address. Systemic effects of smoking. Am J Surg 1984, 148:706-711.
23. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988, 115:242-249.
24. Benowitz N.L. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 1988, 319:1318-1330.
25. Howard G., Wagenknecht L.E., Burke G.L., Diez-Roux A., Evans G.W., McGovern P., Nieto F.J., Tell G.S. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998, 279:119-124.
26. Mehta M., Jain A., Mehta A., Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther 1997, 2:291-298.
27. Stewart P.M., Catterall J.R. Chronic nicotine ingestion and atrial fibrillation. Br Heart J 1985, 54:222-223.
28. Nunes J.P., Barbosa E., Lopes L., Alves C., Goncalves F.R. Nicotine nasal inhalation, atrial fibrillation and seizures. Cardiology 2001, 96:58.
29. Schnabel R.B., Sullivan L.M., Levy D., Pencina M.J., Massaro J.M., D'Agostino R.B., Newton-Cheh C., Yamamoto J.F., Magnani J.W., Tadros T.M., Kannel W.B., Wang T.J., Ellinor P.T., Wolf P.A., Vasan R.S., et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009, 373:739-745.
30. Frost L., Hune L.J., Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 2005, 118:489-495.
31. Wilhelmsen L., Rosengren A., Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 2001, 250:382-389.
32. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995, 98:476-484.
33. Ariansen I., Reims H.M., Gjesdal K., Olsen M.H., Ibsen H., Devereux R.B., Okin P.M., Kjeldsen S.E., Dahlöf B., Wachtell K. Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study. Blood Press 2012, 21:6-11.
34. Heeringa J., Kors J.A., Hofman A., van Rooij F.J., Witteman J.C. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J 2008, 156:1163-1169.
35. Chamberlain A.M., Agarwal S.K., Folsom A.R., Duval S., Soliman E.Z., Ambrose M., Eberly L.E., Alonso A. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm 2011, 8:1160-1166.
36. Suzuki S., Sagara K., Otsuka T., Kano H., Matsuno S., Takai H., Uejima T., Oikawa Y., Koike A., Nagashima K., Kirigaya H., Yajima J., Tanabe H., Sawada H., Aizawa T., et al. Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences. Circ J 2013, 77:2948-2953.
37. Suzuki S., Yamashita T., Otsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Recent mortality of Japanese patients with atrial fibrillation in an urban city of Tokyo. J Cardiol 2011, 58:116-123.
38. Suzuki S., Yamashita T., Ohtsuka T., Sagara K., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Ogasawara K., Sawada H., Aizawa T. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008, 72:914-920.
39. Suzuki S., Sagara K., Otsuka T., Matsuno S., Funada R., Uejima T., Oikawa Y., Yajima J., Koike A., Nagashima K., Kirigaya H., Sawada H., Aizawa T., Yamashita T. A new scoring system for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation. Am J Cardiol 2012, 110:678-682.
40. Suzuki S., Sagara K., Otsuka T., Kanou H., Matsuno S., Uejima T., Oikawa Y., Koike A., Nagashima K., Kirigaya H., Yajima J., Sawada H., Aizawa T., Yamashita T. Estimated glomerular filtration rate and proteinuria are associated with persistent form of atrial fibrillation: analysis in Japanese patients. J Cardiol 2013, 61:53-57.
41. Matsuo S., Imai E., Horio M., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A., Collaborators Developing the Japanese Equation for Estimated GFR Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009, 53:982-992.
42. Pandey M.R. Tobacco smoking and hypertension. J Indian Med Assoc 1999, 97:367-369.
43. Virdis A., Giannarelli C., Neves M.F., Taddei S., Ghiadoni L. Cigarette smoking and hypertension. Curr Pharm Des 2010, 16:2518-2525.
44. Halimi J.-M., Giraudeau B., Vol S., Cacès E., Nivet H., Tichet J. The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 2002, 20:187-193.
45. Watson L., Vonk J.M., Löfdahl C.G., Pride N.B., Pauwels R.A., Laitinen L.A., Schouten J.P., Postma D.S., European Respiratory Society Study on Chronic Obstructive Pulmonary Disease Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med 2006, 100:746-753.
46. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000, 117:1S-4S.
47. Klag M.J., Whelton P.K., Randall B.L., Neaton J.D., Brancati F.L., Ford C.E., Shulman N.B., Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13-18.
48. Halimi J.M., Giraudeau B., Vol S., Caces E., Nivet H., Lebranchu Y., Tichet J. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000, 58:1285-1292.
49. Pinto-Sietsma S.J., Mulder J., Janssen W.M., Hillege H.L., de Zeeuw D., de Jong P.E. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000, 133:585-591.
50. Yoon H.J., Park M., Yoon H., Son K.Y., Cho B., Kim S. The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens Res 2009, 32:214-219.
51. Ishizaka N., Ishizaka Y., Toda E., Shimomura H., Koike K., Seki G., Nagai R., Yamakado M. Association between cigarette smoking and chronic kidney disease in Japanese men. Hypertens Res 2008, 31:485-492.
52. Maeda I., Hayashi T., Sato K.K., Koh H., Harita N., Nakamura Y., Endo G., Kambe H., Fukuda K. Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 2011, 6:2462-2469.
53. Shibata Y., Watanabe T., Osaka D., Abe S., Inoue S., Tokairin Y., Igarashi A., Yamauchi K., Kimura T., Kishi H., Aida Y., Nunomiya K., Nemoto T., Sato M., Konta T., et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 2011, 8:514-522.
54. Buch P., Friberg J., Scharling H., Lange P., Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003, 21:1012-1016.
55. Chiolero A., Faeh D., Paccaud F., Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008, 87:801-809.
56. Sun K., Liu J., Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLOS ONE 2012, 7:e47791.
57. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96:2455-2461.
58. Wanahita N., Messerli F.H., Bangalore S., Gami A.S., Somers V.K., Steinberg J.S. Atrial fibrillation and obesity - results of a meta-analysis. Am Heart J 2008, 155:310-315.
59. Benowitz N.L., Jacob P., Jones R.T., Rosenberg J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 1982, 221:368-372.
60. Haass M., Kubler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 1997, 10:657-665.
61. Wang H., Shi H., Zhang L., Pourrier M., Yang B., Nattel S., Wang Z. Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4.3 channels and native transient outward current. Circulation 2000, 102:1165-1171.
62. Goette A., Lendeckel U., Kuchenbecker A., Bukowska A., Peters B., Klein H.U., Huth C., Röcken C. Cigarette smoking induces atrial fibrosis in humans via nicotine. Heart 2007, 93:1056-1063.
63. Goette A. Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?. Cardiovasc Res 2009, 83:421-422.
64. Shan H., Zhang Y., Lu Y., Zhang Y., Pan Z., Cai B., Wang N., Li X., Feng T., Hong Y., Yang B. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009, 83:465-472.
65. Flaker G.C., Belew K., Beckman K., Vidaillet H., Kron J., Safford R., Mickel M., Barrell P., AFFIRM Investigators Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005, 149:657-663.
66. Gami A.S., Hodge D.O., Herges R.M., Olson E.J., Nykodym J., Kara T., Somers V.K. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49:565-571.
67. Altmann D.R., Ullmer E., Rickli H., Maeder M.T., Sticherling C., Schaer B.A., Osswald S., Ammann P. Clinical impact of screening for sleep related breathing disorders in atrial fibrillation. Int J Cardiol 2012, 154:256-258.
68. Cheng M., Hu Z., Lu X., Huang J., Gu D. Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies. Can J Cardiol 2014, 30:448-454.